236 related articles for article (PubMed ID: 23136886)
1. Direct AMP-activated protein kinase activators: a review of evidence from the patent literature.
Giordanetto F; Karis D
Expert Opin Ther Pat; 2012 Dec; 22(12):1467-77. PubMed ID: 23136886
[TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase modulators: a patent review (2006 - 2010).
Yun H; Ha J
Expert Opin Ther Pat; 2011 Jul; 21(7):983-1005. PubMed ID: 21548715
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
Dymock BW; See CS
Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
[TBL] [Abstract][Full Text] [Related]
4. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
Popovics P; Frigo DE; Schally AV; Rick FG
Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
[TBL] [Abstract][Full Text] [Related]
5. Screening methods for AMP-activated protein kinase modulators: a patent review.
Kim J; Shin J; Ha J
Expert Opin Ther Pat; 2015 Mar; 25(3):261-77. PubMed ID: 25535089
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design.
Miglianico M; Nicolaes GA; Neumann D
J Med Chem; 2016 Apr; 59(7):2879-93. PubMed ID: 26510622
[TBL] [Abstract][Full Text] [Related]
7. Potential upstream regulators and downstream targets of AMP-activated kinase signaling during oocyte maturation in a marine worm.
Stricker SA
Reproduction; 2011 Jul; 142(1):29-39. PubMed ID: 21474604
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.
Arunesh GM; Shanthi E; Krishna MH; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Jan; 24(1):5-17. PubMed ID: 24131033
[TBL] [Abstract][Full Text] [Related]
9. c-MET kinase inhibitors: a patent review (2011 - 2013).
Zhu K; Kong X; Zhao D; Liang Z; Luo C
Expert Opin Ther Pat; 2014 Feb; 24(2):217-30. PubMed ID: 24266843
[TBL] [Abstract][Full Text] [Related]
10. Promise and challenges for direct small molecule AMPK activators.
Olivier S; Foretz M; Viollet B
Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
[TBL] [Abstract][Full Text] [Related]
11. p21-Activated kinase inhibitors: a patent review.
Crawford JJ; Hoeflich KP; Rudolph J
Expert Opin Ther Pat; 2012 Mar; 22(3):293-310. PubMed ID: 22404134
[TBL] [Abstract][Full Text] [Related]
12. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.
Cao W; Li J; Hao Q; Vadgama JV; Wu Y
Breast Cancer Res; 2019 Feb; 21(1):29. PubMed ID: 30791936
[TBL] [Abstract][Full Text] [Related]
13. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
Gehringer M; Muth F; Koch P; Laufer SA
Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
[TBL] [Abstract][Full Text] [Related]
14. AMPK activators--potential therapeutics for metabolic and other diseases.
Zhou G; Sebhat IK; Zhang BB
Acta Physiol (Oxf); 2009 May; 196(1):175-90. PubMed ID: 19245659
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators.
Cameron KO; Kurumbail RG
Bioorg Med Chem Lett; 2016 Nov; 26(21):5139-5148. PubMed ID: 27727125
[TBL] [Abstract][Full Text] [Related]
16. Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation.
Salt IP; Palmer TM
Expert Opin Investig Drugs; 2012 Aug; 21(8):1155-67. PubMed ID: 22694351
[TBL] [Abstract][Full Text] [Related]
17. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of WO-2013040863, WO-2013041042 and WO-2013043962. Selective JAK1 inhibitors based on a 3-aminopyrazole-4-carboxamide scaffold.
Norman P
Expert Opin Ther Pat; 2014 Feb; 24(2):231-7. PubMed ID: 24261748
[TBL] [Abstract][Full Text] [Related]
19. Activation and signaling by the AMP-activated protein kinase in endothelial cells.
Fisslthaler B; Fleming I
Circ Res; 2009 Jul; 105(2):114-27. PubMed ID: 19608989
[TBL] [Abstract][Full Text] [Related]
20. Rho kinase inhibitors: a patent review (2012 - 2013).
Feng Y; LoGrasso PV
Expert Opin Ther Pat; 2014 Mar; 24(3):295-307. PubMed ID: 24283930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]